Cardio Diagnostics Holdings Inc
Save
OverviewDividend safetyDividendsFundamentals
16.17M
Market cap
–
Current P/E
–
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Similar securities

Based on sector and market capitalization

Cocrystal Pharma Inc
Synthetic Biologics, Inc.
Acer Therapeutics Inc.
Numinus Wellness Inc.
Pharma-Bio Serv Inc
Bioxytran, Inc.
Report issue